AG
ITCI

Algert Global’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Algert Global’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,701
Closed -$7.88M – 1378
2025
Q1 		$7.88M Buy
59,701
+34,840
+140% +$4.34M 0.19% 142
2024
Q4 		$2.08M Sell
24,861
-20,489
-45% -$1.68M 0.05% 596
2024
Q3 		$3.32M Sell
45,350
-20,990
-32% -$1.58M 0.09% 398
2024
Q2 		$4.54M Sell
66,340
-64,271
-49% -$4.46M 0.15% 202
2024
Q1 		$9.04M Buy
130,611
+51,001
+64% +$3.51M 0.35% 45
2023
Q4 		$5.7M Buy
79,610
+4,260
+6% +$245K 0.23% 110
2023
Q3 		$3.92M Sell
75,350
-14,124
-16% -$823K 0.18% 170
2023
Q2 		$5.67M Buy
+89,474
New +$5.58M 0.25% 91
2022
Q3 		– Sell
-4,301
Closed -$246K – 1363
2022
Q2 		$246K Buy
+4,301
New +$244K 0.02% 967

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return